Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$55.72 -0.72 (-1.28%)
As of: Oct 21, 2026 · 2:41 PM EDT

Biomarin Pharmaceutical (BMRN) Other financing activities (2009 - 2026)

Updated

Biomarin Pharmaceutical's Other financing activities was $37.42 million in Q2 2026, up 204.0% from $12.31 million a year earlier and up 32.8% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Other financing activities (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Biomarin Pharmaceutical's Other financing activities was $70.48 million through Jun 30, 2026, up 13.8% year-over-year; for FY2025, it was $55.97 million, down 27.8% from FY2024.

  • Other financing activities shows a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
  • In earlier years, Other financing activities was $77.56 million in FY2024 (+1.6%), $76.32 million in FY2023 (+40.6%), $54.28 million in FY2022 (+18.5%) and $45.81 million in FY2021 (+2.6%).
  • The Q2 2026 figure marks the highest quarterly Other financing activities since Q1 2025.
  • Compared with a year earlier, Other financing activities was higher in three of the last eight quarters, with growth averaging 9.4%.
  • The best year-over-year quarter for Other financing activities over five years was Q2 2026 (growth of 204.0%); the worst was Q3 2025 (a decline of 63.2%).
  • Per Business Quant data, BMRN's Other financing activities in the three quarters before Q2 2026 was $28.18 million (Q1 2026), $2.7 million (Q4 2025) and $2.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.90 Bn 1,105.48 Bn 19.71 Bn
2 Johnson & Johnson 617.06 Bn 535.59 Bn 17.26 Bn
3 AbbVie 501.38 Bn 474.49 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn
6 Astrazeneca 261.31 Bn 235.00 Bn 12.86 Bn
7 Amgen 236.29 Bn 191.69 Bn 7.24 Bn
8 Gilead Sciences 190.40 Bn 164.60 Bn 6.22 Bn
9 Pfizer 169.55 Bn 116.19 Bn 10.94 Bn
10 Biomarin Pharmaceutical 10.76 Bn 4.63 Bn 786.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -68.28 Mn
Mar 31, 2026 -36.83 Mn
Dec 31, 2025 -3.59 Mn
Sep 30, 2025 -2.18 Mn
Jun 30, 2025 -12.31 Mn
Mar 31, 2025 -38.78 Mn
Dec 31, 2024 -5.00 Mn
Sep 30, 2024 -8.94 Mn
Jun 30, 2024 -16.81 Mn
Mar 31, 2024 -49.99 Mn
Dec 31, 2023 -3.97 Mn
Sep 30, 2023 -6.78 Mn
Jun 30, 2023 -16.44 Mn
Mar 31, 2023 -60.90 Mn
Dec 31, 2022 -16.23 Mn
Sep 30, 2022 -6.32 Mn
Jun 30, 2022 -32.48 Mn
Mar 31, 2022 -32.95 Mn
Dec 31, 2021 -1.37 Mn
Sep 30, 2021 -5.72 Mn
API Access

Biomarin Pharmaceutical Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=BMRN&period=max&api_key=YOUR_API_KEY